Colon Screening Market Size To Reach $57.65 Billion By 2033

Colon Screening Market Growth & Trends

The global colon screening market size is expected to reach USD 57.65 billion by 2033, registering a CAGR of 4.60% from 2026 to 2033, according to a new report by Grand View Research, Inc. The growing prevalence of colorectal cancer, increasing government initiatives to encourage cancer screening, and ongoing technological advancements in the market are major factors driving the market growth. According to CDC data published in June 2024, the prevalence of IBD in the U.S. is estimated between 2.4 and 3.1 million. Similarly, the worldwide prevalence of ulcerative colitis was expected to be 5 million in 2023.

The development of technologically advanced products in colon screening has significantly contributed to the market's growth. These innovations have enhanced diagnostic accuracy, improved patient comfort, minimized risks associated with traditional procedures, and enabled earlier detection of colon-related diseases, including cancer and polyps. For instance, in May 2024, FUJIFILM launched two innovative endoscopic imaging technologies: CAD EYE and SCALE EYE. CAD EYE is an AI-powered system designed to enhance the detection of colonic mucosal lesions such as polyps and adenomas during colonoscopy.

In addition, the increasing efforts by private and public players worldwide to increase awareness and accessibility of colon screening have further driven the market across different regions. For instance, in November 2024, Guam Regional Medical City introduced an advanced capsule endoscopy service funded by a grant from the USDA Rural Development Program. This innovative, minimally invasive diagnostic solution represents a significant advancement in gastrointestinal healthcare for Guam and the surrounding region, enhancing medical technology while prioritizing patient comfort. Such developments increase access to advanced diagnosis services, thus driving market growth.

Moreover, the widespread adoption of routine screening programs has an effective role in detecting cancers & precancerous polyps. In addition, advancements in colonoscopy technology, including AI-assisted detection, have improved diagnostic efficiency and patient outcomes. For instance, in December 2023, Medtronic expanded its artificial intelligence collaboration with Cosmo Pharmaceuticals, the developer of plug-in software designed to detect health issues during endoscopic examinations automatically.

Key players in the market are engaged in technological advancements, new product launches, and partnerships & collaborations to gain a higher market share. For instance, in February 2022, Medtronic collaborated with the American Society for Gastrointestinal Endoscopy (ASGE) to offer AI-powered colonoscopy technology for colorectal cancer screening in underserved communities of the U.S.

 Request a free sample copy or view report summary: Colon Screening Market Report

Colon Screening Market Report Highlights

• By type, the test segment dominated the market with the largest revenue share of 81.24% in 2025. The growing demand for non-invasive and simple screening procedures is driving the growth of the test segment in the market.

• By end use, the hospitals segment dominated the market with a revenue share of 51.20% in 2025. Factors such as availability and increasing adoption of advanced imaging technologies and personalized screening pathways to enhance diagnostic accuracy.

• North America colon screening market dominated with a revenue share of 53.12% in 2025. A well-established regulatory framework and ongoing efforts to promote disease screenings are expected to support market growth further.

Colon Screening Market Segmentation

Grand View Research has segmented the global colon screening market on the basis of type and region:

Colon Screening Type Outlook (Revenue, USD Million, 2021 - 2033)

• Test

  • Colonoscopy

  • Capsule Endoscopy

  • Imaging Tests

    • Virtual Colonoscopy

    • Magnetic resonance colonography (MRC)

  • Others

  • End Use, By Test

    • Hospitals

    • Outpatient Facilities

• Product

  • Colonoscopes

  • Sigmoidoscopes

  • CT Scanners

  • Magnetic Resonance Imaging (MRI)

  • End Use, By Product

    • Hospitals

    • Outpatient Facilities

Colon Screening Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Colon Screening Market

• Olympus

• PENTAX Medical (Hoya Corporation)

• FUJIFILM Holdings Corporation

• Medtronic

• Ambu A/S

• Baxter (Hillrom & Welch Allyn)

• EndoFresh (Daichuan medical)

• Bracco

• Varay Laborix